Jan 24, 2022
Version 2
The efficacy of telemedicine using videoconferencing system in outpatient care for cancer patients: a systematic review and meta-analysis protocol V.2
- Yasuaki Uemoto1,
- Taro Yamanaka2,
- Yuki Kataoka3,
- Yoshitaka Wada4,
- Yosuke Aoyama2,
- Rika Kizawa2,
- Yu Yamaguchi2,
- Yuichiro Kikawa5,
- Hirohumi Mukai6,
- Naruto Taira7
- 1Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan;
- 2Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.;
- 3Department of Internal Medicine, Kyoto Min-Iren Asukai Hospital, Tanaka Asukai-cho 89, Sakyo-ku, Kyoto 606-8226, JAPAN;
- 4Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University, Aichi, 470-1192, Japan;
- 5DepartmeDepartment of Breast Surgery, Kansai Medical University Hospital, Hirakata, Japan.;
- 6Division of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan;
- 7Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, 700-8558, Japan
- teleoncology_SR
Protocol Citation: Yasuaki Uemoto, Taro Yamanaka, Yuki Kataoka, Yoshitaka Wada, Yosuke Aoyama, Rika Kizawa, Yu Yamaguchi, Yuichiro Kikawa, Hirohumi Mukai, Naruto Taira 2022. The efficacy of telemedicine using videoconferencing system in outpatient care for cancer patients: a systematic review and meta-analysis protocol. protocols.io https://dx.doi.org/10.17504/protocols.io.b38qqrvwVersion created by Yasuaki Uemoto
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it’s working
Created: January 24, 2022
Last Modified: January 24, 2022
Protocol Integer ID: 57328
Keywords: neoplasms, carcinoma, cancer, tumor, malignan*, telemedicine, videoconferencing, videoconferencing, remote consultation, telehealth, mhealth, ehealth, mobile health,
Disclaimer
DISCLAIMER – FOR INFORMATIONAL PURPOSES ONLY; USE AT YOUR OWN RISK
The protocol content here is for informational purposes only and does not constitute legal, medical, clinical, or safety advice, or otherwise; content added to protocols.io is not peer reviewed and may not have undergone a formal approval of any kind. Information presented in this protocol should not substitute for independent professional judgment, advice, diagnosis, or treatment. Any action you take or refrain from taking using or relying upon the information presented here is strictly at your own risk. You agree that neither the Company nor any of the authors, contributors, administrators, or anyone else associated with protocols.io, can be held responsible for your use of the information contained in or linked to this protocol or any of our Sites/Apps and Services.
Abstract
Further research is needed to compare the impact of interactive Telemedicine using videoconferencing systems with usual face-to-face care in the outpatient with cancer. The aim of this study is to review systematically the efficacy of interactive telemedicine using videoconferencing systems in this setting, including feasibility, satisfaction and cost.
Attachments
